The researchers included data that represented more than 270 million Americans and 12.9 million Medicare supplemental beneficiaries.

Researchers divided US registry data from the National Cancer Database into derivation and validation cohorts in order to reappraise HPV-positive oropharyngeal carcinoma pathological staging.